Breaking down type 2 inflammation as the predominant inflammatory pathway in AD through to adulthood from biomarker studies.
In this short video, Dr. Amy Paller compares the cytokine subset development from infancy to adulthood in healthy patients with profiles in AD patients, noting the key differences that support the dominant role of type 2 inflammatory pathway in AD.
Walter J. Hamlin Professor and Chair of Dermatology; Professor of Pediatrics at Northwestern University, Evanston, Illinois, US
See author’s profile